Results 151 to 160 of about 153,892 (355)

Prognosis of Invasive Lobular Carcinoma and Effectiveness of Eribulin in Clinical Practice: A Post Hoc Analysis of a 2‐Year Post‐Marketing Surveillance

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
This post hoc analysis of a post‐marketing surveillance evaluated the prognosis of patients with invasive lobular carcinoma (ILC) or invasive ductal carcinoma (IDC) treated with eribulin. Overall survival (OS) from the first‐line chemotherapy was shorter for ILC than IDC cases, but OS from the first date of eribulin administration were similar between ...
Yuko Tanabe   +10 more
wiley   +1 more source

Do the oral Staphylococcus aureus strains from denture wearers have a greater pathogenicity potential?

open access: yesJournal of Oral Microbiology, 2019
We used flow cytometry to compare the phagocytic activity of monocytes against Staphylococcus aureus strains (both biofilm and planktonic cells) isolated from denture wearers and non-wearers.
Katarzyna Garbacz   +4 more
doaj   +1 more source

Development and characterisation of a fully recombinant competition ELISA for the diagnosis of foot‐and‐mouth disease virus infection

open access: yesAustralian Veterinary Journal, EarlyView.
Infection of livestock by foot‐and‐mouth disease (FMD) virus (FMDV) has serious economic implications due to productivity losses and trade restrictions. In countries that are free from foot and mouth disease, the World Organisation for Animal Health (WOAH) provides two proof of freedom from disease status categories; namely, FMD‐free without using ...
S Ye   +7 more
wiley   +1 more source

Erythematous Papules and Plaques in an Infant Receiving Glucagon Therapy

open access: yes
JEADV Clinical Practice, EarlyView.
Sara Al Janahi   +4 more
wiley   +1 more source

PI3Kδ Inhibitor Parsaclisib in Japanese Patients With Relapsed or Refractory Follicular Lymphoma

open access: yesCancer Science, EarlyView.
CITADEL‐213 evaluated the efficacy and safety of parsaclisib (PI3Kδ inhibitor) in Japanese patients with relapsed or refractory follicular lymphoma (R/R FL). The objective response rate was 88.1%, with 23.8% of patients experiencing a complete response and 64.3% experiencing a partial response; treatment‐emergent adverse events led to parsaclisib ...
Noriko Fukuhara   +15 more
wiley   +1 more source

Stomatitis for Diagnosis [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1956
R. G. Howell, G. B. Mitchell-Heggs
openaire   +3 more sources

Home - About - Disclaimer - Privacy